AMDA (9-Aminomethyl-910-dihydroanthracene) is an organic compound which acts as a potent and selective antagonist for the 5-HT2A receptor. It has been used to help study the shape of the 5-HT2A protein and develop a large family of related derivatives with even higher potency and selectivity.